AR and prostate cancer: The fact that single CCG1423 treatment varies in prostate cancer cell lines with different AR levels (LNCaP parental, LNCaP Abl and PC3), as well as in the same cell line (LNCaP Abl), depending on DHT stimulation, indicates that AR involvement in this process is important.